Share This Page
Suppliers and packagers for generic pharmaceutical drug: TOPOTECAN HYDROCHLORIDE
✉ Email this page to a colleague
TOPOTECAN HYDROCHLORIDE
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Sandoz | HYCAMTIN | topotecan hydrochloride | CAPSULE;ORAL | 020981 | NDA | Novartis Pharmaceuticals Corporation | 0078-0672-01 | 10 CAPSULE in 1 BOTTLE (0078-0672-01) | 2017-07-07 |
| Sandoz | HYCAMTIN | topotecan hydrochloride | CAPSULE;ORAL | 020981 | NDA | Novartis Pharmaceuticals Corporation | 0078-0673-01 | 10 CAPSULE in 1 BOTTLE (0078-0673-01) | 2017-02-24 |
| Sandoz | HYCAMTIN | topotecan hydrochloride | CAPSULE;ORAL | 020981 | NDA | Sandoz Inc | 66758-101-11 | 10 CAPSULE in 1 BOTTLE (66758-101-11) | 2017-07-07 |
| Sandoz | HYCAMTIN | topotecan hydrochloride | CAPSULE;ORAL | 020981 | NDA | Sandoz Inc | 66758-102-11 | 10 CAPSULE in 1 BOTTLE (66758-102-11) | 2017-02-24 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: Topotecan Hydrochloride
Introduction
Topotecan Hydrochloride is a chemotherapeutic agent used primarily in the treatment of ovarian cancer, small cell lung cancer, and other malignancies. As a semi-synthetic derivative of camptothecin, it functions by inhibiting topoisomerase I, an enzyme critical for DNA replication. Given its therapeutic importance, a reliable supply chain of high-quality Topotecan Hydrochloride is vital for pharmaceutical manufacturers, healthcare providers, and research institutions. This report analyses the leading suppliers, the market landscape, regulatory considerations, and strategic factors influencing sourcing decisions.
Market Overview and Demand Factors
The global oncology drugs market is on an upward trajectory, driven by increasing cancer prevalence and advances in targeted therapies. Topotecan Hydrochloride’s patent expiry has opened the market to multiple generic producers, expanding supply options but also intensifying competition. The drug’s complex synthesis, strict quality requirements, and regulatory oversight necessitate suppliers with robust manufacturing capabilities and stringent quality management systems.
Key Suppliers of Topotecan Hydrochloride
1. Fuan Pharmaceutical Co., Ltd.
Overview: Based in China, Fuan Pharmaceutical is recognized for its robust portfolio in producing active pharmaceutical ingredients (APIs), including Topotecan Hydrochloride. The company emphasizes quality assurance and adheres to GMP standards, conforming to both Chinese and international regulatory frameworks.
Capabilities:
- Large-scale manufacturing with scalable supply capacity
- Certification: cGMP, ISO 9001, DMF registration in the US and Europe
- Focus on R&D to optimize synthetic processes and improve yield
Market Presence:
Fuan supplies to multiple regional markets, including North America, Europe, and Asia. Their strategic partnerships facilitate export logistics and regulatory compliance.
2. Jiangsu Hengrui Medicine Co., Ltd.
Overview:
A leading Chinese pharmaceutical company, Hengrui is known for its innovative oncology pipeline and manufacturing expertise in APIs. The company has obtained approvals for several oncology drugs and APIs, including Topotecan Hydrochloride.
Capabilities:
- Integrated production processes ensuring consistent quality
- Comprehensive GMP certification and rigorous quality control protocols
- Active participation in global pharmacopoeias and regulatory submissions
Market Presence:
Hengrui’s products are distributed globally, with particularly strong footprints in Asia and emerging markets.
3. Teva Pharmaceutical Industries Ltd.
Overview:
As one of the world’s largest generic drug manufacturers, Teva offers Topotecan Hydrochloride among its extensive oncology API portfolio. Their manufacturing facilities in Israel and Europe meet high regulatory standards.
Capabilities:
- Proven track record of compliance with US FDA, EMA, and other global agencies
- Well-established supply chain logistics and distribution networks
- Capability to supply large volumes reliably
Market Presence:
Teva’s global footprint ensures stability and compliance in supply, essential for large-volume pharmaceutical manufacturers.
4. Wikvet Corporation
Overview:
A notable Indian API producer, Wikvet specializes in chemotherapeutic agents, including Topotecan Hydrochloride. The company emphasizes cost-effective manufacturing without compromising quality.
Capabilities:
- ISO-certified facilities with Good Manufacturing Practice compliance
- Competitive pricing favored by generic pharmaceutical companies
- Focus on quality assurance and stability testing
Market Presence:
Wikvet primarily supplies to API distributors and generic manufacturers across Asia, Africa, and Latin America.
5. Other Notable Suppliers
- Zhejiang Hisun Pharmaceutical Co., Ltd. (China): Focused on oncology APIs with a strong R&D backbone.
- Lupin Limited (India): Engaged in large-scale generic API production, including Topotecan Hydrochloride.
- Sandoz (Novartis): Offers high-quality APIs with strict regulatory adherence, primarily for institutional and branded pharmaceutical use.
Regulatory and Quality Considerations
Suppliers must meet rigorous standards dictated by regulatory agencies such as the U.S. FDA, European EMA, and China’s NMPA. Certificates of Analysis (CoA), drug master files (DMFs), and compliance with Good Manufacturing Practice (GMP) are prerequisites. Suppliers with established regulatory dossiers streamline approval processes for pharmaceutical companies seeking to incorporate Topotecan Hydrochloride into their product lines.
Strategic Sourcing Insights
- Quality Assurance: Prioritize suppliers with proven GMP compliance, validated manufacturing processes, and comprehensive quality documentation.
- Supply Stability: Establish relationships with suppliers capable of scalable and consistent production, especially in the face of increasing global cancer treatments.
- Regulatory Alignment: Select suppliers with registered DMFs and validated dossiers in target markets to facilitate fast regulatory approval and reduce market entry time.
- Cost Considerations: While price is essential, balance it against quality, regulatory support, and supplier credibility. Indian and Chinese manufacturers often present cost-competitive options.
Supply Chain Challenges and Solutions
- Regulatory Variability: Different countries impose varying standards. Establish supplier compliance tracks and validate their registrations across regions.
- Manufacturing Disruptions: Reliance on a limited number of suppliers can pose risks. Diversify supply sources to mitigate geopolitical and operational risks.
- Intellectual Property: Although Topotecan Hydrochloride’s patents have expired, maintaining supplier transparency regarding proprietary processes is critical.
Conclusion
A diversified supplier base comprising high-quality Chinese manufacturers such as Fuan Pharmaceutical and Jiangsu Hengrui, established global players like Teva, and capable Indian firms such as Wikvet offers robust options for sourcing Topotecan Hydrochloride. Strategic evaluation based on regulatory compliance, manufacturing capacity, quality assurance, and cost effectiveness will enhance supply security and support pharmaceutical innovation.
Key Takeaways
- Global top suppliers include Fuan Pharmaceutical, Jiangsu Hengrui, Teva, and Wikvet, among others.
- Ensuring GMP compliance and regulatory registration expedites market approval.
- Diversification of suppliers mitigates supply chain risks.
- Cost-effective sourcing can be achieved without compromising quality by engaging qualified Indian and Chinese manufacturers.
- Continuous monitoring of regulatory changes and manufacturing capacity is critical for supply chain resilience.
Frequently Asked Questions (FAQs)
1. What are the main regions supplying Topotecan Hydrochloride globally?
China and India are primary sources of generic manufacturing, while multinational companies like Teva provide globally compliant APIs. Manufacturing hubs in China, India, and Israel dominate global supply.
2. How do regulatory standards impact supplier selection for Topotecan Hydrochloride?
Regulatory compliance, including GMP certification and DMF registration, ensures API quality, accelerates approvals, and minimizes manufacturing delays. Suppliers must align with agencies like the FDA and EMA.
3. What factors influence the cost of Topotecan Hydrochloride APIs?
Production scale, raw material availability, manufacturing efficiency, regulatory compliance costs, and geopolitical factors influence pricing.
4. Are there any risks associated with sourcing Topotecan Hydrochloride from Chinese or Indian suppliers?
Potential risks include regulatory divergences, manufacturing consistency, and geopolitical considerations. Conducting thorough supplier audits and validation mitigates these risks.
5. How can pharmaceutical companies ensure a stable supply of Topotecan Hydrochloride?
Building relationships with multiple suppliers, engaging with companies holding validated GMP and DMF registrations, and maintaining strategic stockpiles contribute to supply stability.
Sources:
- Pharma & Biotech Supply Chain Reports, 2022.
- US FDA Drug Master Files, 2023.
- Jiangsu Hengrui Medicine Official Website.
- Teva Pharmaceuticals Product Portfolio.
- Industry Analyses on Oncology API Markets, 2023.
More… ↓
